Matthew Guo
Impact in
- Nephrology top 0.5%
- Parathyroid Disorders and Treatments
-
- Gastric Cancer Management and Outcomes
- Sarcoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
Papers in
- Hematology 16
- Platelet Disorders and Treatments 10
- Blood groups and transfusion 5
- Hematopoietic Stem Cell Transplantation 4
-
- Parathyroid Disorders and Treatments 5
- Renal Diseases and Glomerulopathies 4
- Co-authors
- Jonathan J. BeitlerAnthony H. RussellArnold HerskovicRoger W. ByhardtJay S. CooperLawrence LeichmanSharon A. SpencerJames A. Martenson
- Journals
- Journal of Clinical Oncology (14 papers)Blood (13 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)JAMA (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Matthew Guo
44 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Nephrology 903
- Pulmonary and Respiratory Medicine 2.2k
- Oncology 1.5k
- Hematology 531
- Surgery 1.7k
Countries citing papers authored by Matthew Guo
This map shows the geographic impact of Matthew Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Guo more than expected).
Fields of papers citing papers by Matthew Guo
This network shows the impact of papers produced by Matthew Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Guo. The network helps show where Matthew Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2019 | 3 | |
| 3 | 2019 | 2 | |
| 4 | Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 360 |
| 5 | 2019 | 9 | |
| 6 | 2018 | 68 | |
| 7 | 2017 | 129 | |
| 8 | 2017 | 135 | |
| 9 | 2017 | 31 | |
| 10 | 2016 | 1 | |
| 11 | 2016 | 6 | |
| 12 | 2009 | 18 | |
| 13 | 2008 | 113 | |
| 14 | 2007 | 6 | |
| 15 | 2005 | 312 | |
| 16 | 2005 | 41 | |
| 17 | 2005 | 102 | |
| 18 | 2005 | 309 | |
| 19 | 2003 | 181 | |
| 20 | Chemoradiotherapy of Locally Advanced Esophageal Cancer Hit paper breakdown → | 1999 | 1457 |
About Matthew Guo
Matthew Guo is a scholar working on Hematology, Nephrology, Oncology, Cancer Research and Obstetrics and Gynecology, having authored 45 papers that have together received 4.6k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), Parathyroid Disorders and Treatments (5 papers), Blood groups and transfusion (5 papers), Renal Diseases and Glomerulopathies (4 papers), Cancer Genomics and Diagnostics (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Nephrology (903 citations), Pulmonary and Respiratory Medicine (2.2k citations), Oncology (1.5k citations), Hematology (531 citations) and Surgery (1.7k citations). Matthew Guo has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Jonathan J. Beitler, Anthony H. Russell, Arnold Herskovic, Roger W. Byhardt, Jay S. Cooper, Lawrence Leichman, Sharon A. Spencer, James A. Martenson, Sucha O. Asbell and John S. Macdonald. Their work appears in journals such as Journal of Clinical Oncology, Blood, The Journal of Clinical Endocrinology & Metabolism, JAMA and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.